You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 61 No. 5, May 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (4)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Alzheimer Disease
 •Neuropathology
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Serum Copper

A Biomarker for Alzheimer Disease?

Arch Neurol. 2004;61:631-632.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Alzheimer disease (AD) is causally related to the buildup of {beta}-amyloid (A{beta}), a 39– to 43–amino acid protein, in the brain. Increasing evidence has implicated a biochemical association with copper in this neuropathologic condition. Copper is essential for life, mediating the activities of the respiratory chain of copper-binding proteins (cytochromes) in the mitochondria. Yet, the electron transfer chemistry of copper ion (Cu2+) also makes it potentially a pro-oxidant when it inappropriately reacts with oxygen (generating reactive oxygen species), proteins, or other biochemicals. For this reason, it is believed that copper ions in the cell are not in a free ionic chemical form, but rather are stringently transported and regulated by the action of several protein carriers, such as the Menkes and Wilson disease adenosine triphosphatases.

{beta}-Amyloid is a high-affinity cuproprotein, bound to copper when purified from postmortem AD-affected brain tissue.1 The interaction of Cu2+ with A{beta} appears to . . . [Full Text of this Article]

Ashley I. Bush, MD, PhD
Laboratory of Oxidation Biology
Genetics and Aging Research Unit
Massachusetts General Hospital East
Bldg 114, 16th Street
Charlestown, MA 02129
(e-mail: bush@helix.mgh.harvard.edu)

Dorothea Strozyk, MD
Valhalla, NY



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Copper Perturbation in 2 Monozygotic Twins Discordant for Degree of Cognitive Impairment
Rosanna Squitti, Emanuele Cassetta, Gloria Dal Forno, Domenico Lupoi, Giulia Lippolis, Flavia Pauri, Fabrizio Vernieri, Antonella Cappa, and Paolo M. Rossini
Arch Neurol. 2004;61(5):738-743.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.